Tyrosine kinase inhibitors as potential sensitizers of adoptive T cell therapy for hepatocellular carcinoma.

Saved in:

Bibliographic Details
Title:	Tyrosine kinase inhibitors as potential sensitizers of adoptive T cell therapy for hepatocellular carcinoma.
Authors:	Liang L; Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.; Department of Oncology, Shenzhen Qianhai Shekou Free Trade Zone Hospital, Shenzhen, Guangdong, China., Wang X; Department of Oncology, Shenzhen Qianhai Shekou Free Trade Zone Hospital, Shenzhen, Guangdong, China., Huang S; Department of Oncology, Shenzhen Qianhai Shekou Free Trade Zone Hospital, Shenzhen, Guangdong, China., Chen Y; Department of Pulmonary Critical Care Medicine of Tangdu Hospital, Fourth Military Medical University, Xi'an, China., Zhang P; Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China., Li L; School of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong, China., Cui Y; Department of Oncology, Shenzhen Qianhai Shekou Free Trade Zone Hospital, Shenzhen, Guangdong, China.
Source:	Frontiers in immunology [Front Immunol] 2023 Mar 01; Vol. 14, pp. 1046771. Date of Electronic Publication: 2023 Mar 01 (Print Publication: 2023).
Publication Type:	Journal Article; Review; Research Support, Non-U.S. Gov't
Journal Info:	Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1664-3224
DOI:	10.3389/fimmu.2023.1046771